Vanda Pharmaceuticals Inc. (VNDA) › Shares OutstandingVanda Pharmaceuticals Inc. (VNDA) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 28.04M2011-12-31: 28.12M2012-12-31: 28.24M2013-12-31: 33.34M2014-12-31: 41.49M2015-12-31: 42.82M2016-12-31: 44.00M2017-12-31: 44.94M2018-12-31: 52.48M2019-12-31: 53.55M2020-12-31: 54.87M2021-12-31: 55.90M2022-12-31: 56.78M2023-12-31: 57.53M2024-12-31: 58.31M2025-12-31: 59.10M59.10M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3159.10M+1.4%2026-02-12Balance as of period end2024-12-3158.31M+1.3%2026-02-12Balance as of period end2023-12-3157.53M+1.3%2025-02-14Balance as of period end2022-12-3156.78M+1.6%2024-02-08Balance as of period end2021-12-3155.90M+1.9%2023-02-09Balance as of period end2020-12-3154.87M+2.5%2022-02-24Balance as of period end2019-12-3153.55M+2.0%2021-02-11Balance as of period end2018-12-3152.48M+16.8%2020-02-26Balance as of period end2017-12-3144.94M+2.1%2019-02-19Balance as of period end2016-12-3144.00M+2.8%2018-02-15Balance as of period end2015-12-3142.82M+3.2%2017-02-17Balance as of period end2014-12-3141.49M+24.4%2016-02-12Balance as of period end2013-12-3133.34M+18.0%2015-03-13Balance as of period end2012-12-3128.24M+0.4%2014-02-25Balance as of period end2011-12-3128.12M+0.3%2013-02-26Balance as of period end2010-12-3128.04M—2012-03-09Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)